Skip to main content

Cellectis S.A.

CLLS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001627281

No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Cellectis S.A. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of CLLS: Q1 2021 compared with Q2 2021
MeasureQ1 2021Of which not filed for Q2 2021Q2 2021Change
Holders81278−1
Shares15.2M38.7K16.2M+1.01M (+6.6%)
Value$308.0M$781.0K$250.6M−$56.6M (−18.4%)

2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Cellectis S.A. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CLLS in Q2 2021
InstitutionSharesValue% of portfolio
Principal Financial Group Inc1,262,388$19.5M0.01%
Baillie Gifford & Co1,033,872$16.0M0.01%
Vident Investment Advisory, LLC14,268$221.0K0.01%
Ameriprise Financial Inc11,822$184.0K0.00%
Gladstone Institutional Advisory LLC11,641$180.0K0.02%
Acadian Asset Management LLC3,227$50.0K0.00%
Quadrant Capital Group LLC694$11.0K0.00%
Advisory Services Network, LLC100$2.00K0.00%
Signaturefd, LLC33$1.00K0.00%

Sold out (10)

Institutions that held Cellectis S.A. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of CLLS in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Migdal Insurance & Financial Holdings Ltd.23,224$469.0K
Two Sigma Advisers, LP17,912$362.0K
HRT Financial LP17,486$353.0K
Bank of New York Mellon Corp13,000$262.0K
Tekla Capital Management LLC11,955$242.0K
New York Life Investments Alternatives10,664$216.0K
RMR Wealth Builders2,035$41.0K
Bank of Montreal500$10.0K
Logan Capital Management Inc500$10.0K
Sowell Financial Services LLC371$6.00K

Not filed for Q2 2021 yet (2)

Institutions that held Cellectis S.A. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CLLS in Q1 2021 that haven't filed for Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
OneAscent Wealth Management LLC26,377$533.0K
OneAscent Financial Services LLC12,294$248.0K